GlaxoSmithKline plc (LON:GSK) Insider Acquires £138.48 in Stock

Share on StockTwits

GlaxoSmithKline plc (LON:GSK) insider Emma Walmsley acquired 8 shares of the stock in a transaction that occurred on Tuesday, December 10th. The shares were bought at an average price of GBX 1,731 ($22.77) per share, with a total value of £138.48 ($182.16).

Emma Walmsley also recently made the following trade(s):

  • On Monday, November 11th, Emma Walmsley acquired 7 shares of GlaxoSmithKline stock. The stock was bought at an average cost of GBX 1,727 ($22.72) per share, with a total value of £120.89 ($159.02).
  • On Wednesday, October 9th, Emma Walmsley bought 7 shares of GlaxoSmithKline stock. The stock was bought at an average price of GBX 1,729 ($22.74) per share, for a total transaction of £121.03 ($159.21).

Shares of GSK stock traded up GBX 2.80 ($0.04) during trading hours on Wednesday, hitting GBX 1,753 ($23.06). 6,938,436 shares of the company’s stock traded hands, compared to its average volume of 9,120,000. The stock has a market cap of $87.55 billion and a PE ratio of 19.20. The stock’s 50 day simple moving average is GBX 1,725.16 and its 200 day simple moving average is GBX 1,662.96. The company has a quick ratio of 0.50, a current ratio of 0.82 and a debt-to-equity ratio of 183.00. GlaxoSmithKline plc has a 12 month low of GBX 1,421.80 ($18.70) and a 12 month high of GBX 1,796.40 ($23.63).

The firm also recently disclosed a dividend, which will be paid on Thursday, January 9th. Investors of record on Thursday, November 14th will be paid a GBX 19 ($0.25) dividend. The ex-dividend date is Thursday, November 14th. This represents a dividend yield of 1.07%. GlaxoSmithKline’s dividend payout ratio is 1.01%.

A number of analysts have weighed in on GSK shares. Credit Suisse Group boosted their target price on shares of GlaxoSmithKline from GBX 1,700 ($22.36) to GBX 1,800 ($23.68) and gave the stock a “neutral” rating in a research note on Thursday, October 31st. Citigroup reiterated a “neutral” rating on shares of GlaxoSmithKline in a research note on Thursday, November 7th. DZ Bank raised their price objective on GlaxoSmithKline from GBX 1,850 ($24.34) to GBX 2,000 ($26.31) and gave the company a “buy” rating in a report on Thursday, October 31st. Goldman Sachs Group set a GBX 1,900 ($24.99) price objective on GlaxoSmithKline and gave the stock a “buy” rating in a research report on Wednesday, October 30th. Finally, JPMorgan Chase & Co. set a GBX 1,700 ($22.36) target price on GlaxoSmithKline and gave the stock a “neutral” rating in a report on Wednesday, October 30th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and five have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus target price of GBX 1,794.64 ($23.61).

About GlaxoSmithKline

GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare.

Recommended Story: Put Option Volume

Insider Buying and Selling by Quarter for GlaxoSmithKline (LON:GSK)

Receive News & Ratings for GlaxoSmithKline Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Bowling Portfolio Management LLC Trims Stock Holdings in PennyMac Financial Services Inc
Bowling Portfolio Management LLC Trims Stock Holdings in PennyMac Financial Services Inc
Evertec Inc  Shares Sold by Bowling Portfolio Management LLC
Evertec Inc Shares Sold by Bowling Portfolio Management LLC
Bowling Portfolio Management LLC Increases Position in Home Depot Inc
Bowling Portfolio Management LLC Increases Position in Home Depot Inc
Bowling Portfolio Management LLC Has $1.31 Million Stake in Chevron Co.
Bowling Portfolio Management LLC Has $1.31 Million Stake in Chevron Co.
Bowling Portfolio Management LLC Has $7.92 Million Stock Position in Verizon Communications Inc.
Bowling Portfolio Management LLC Has $7.92 Million Stock Position in Verizon Communications Inc.
Orrstown Financial Services Inc. Sells 114 Shares of Home Depot Inc
Orrstown Financial Services Inc. Sells 114 Shares of Home Depot Inc


 
© 2006-2020 Zolmax.